0001493152-17-000429.txt : 20170113 0001493152-17-000429.hdr.sgml : 20170113 20170112215755 ACCESSION NUMBER: 0001493152-17-000429 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170113 DATE AS OF CHANGE: 20170112 EFFECTIVENESS DATE: 20170113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MultiCell Technologies, Inc. CENTRAL INDEX KEY: 0000811779 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521412493 STATE OF INCORPORATION: DE FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-16354 FILM NUMBER: 17526317 BUSINESS ADDRESS: STREET 1: 68 CUMBERLAND STREET, SUITE 301 CITY: WOONSOCKET STATE: RI ZIP: 02865 BUSINESS PHONE: (401)762-0045 MAIL ADDRESS: STREET 1: 68 CUMBERLAND STREET, SUITE 301 CITY: WOONSOCKET STATE: RI ZIP: 02865 FORMER COMPANY: FORMER CONFORMED NAME: Multicell Technologies Inc. DATE OF NAME CHANGE: 20040615 FORMER COMPANY: FORMER CONFORMED NAME: EXTEN INDUSTRIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: EXTEN VENTURES INC DATE OF NAME CHANGE: 19910923 15-12G 1 form15-12g.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 001-10221

 

MultiCell Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

68 Cumberland Street, Suite 301

Woonsocket, Rhode Island 02895

(401) 762-0045

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, Par Value $0.01 Per Share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

  Rule 12g-4(a)(1) [  ]
  Rule 12g-4(a)(2) [X]
  Rule 12h-3(b)(1)(i) [  ]
  Rule 12h-3(b)(1)(ii) [  ]
  Rule 15d-6 [  ]
  Rule 15d-22(b) [  ]

 

Approximate number of holders of record as of the certification or notice date: 359.

 

Pursuant to the requirements of the Securities Exchange Act of 1934, MultiCell Technologies, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: January 12, 2017 By: /s/ W. Gerald Newman
  Name: W. Gerald Newman
  Title: Chief Executive Officer, Chief Financial Officer